• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 83 of 100
Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
HealthMartin Shkreli Seriously Didn’t Care About Jacking Up Drug Prices
By Laura LorenzettiFebruary 3, 2016
Merck & Co. diabetes treatment Januvia sits is arranged for
FinanceMerck’s Blockbuster Drugs Are Losing Steam
By ReutersFebruary 3, 2016
Views Of A CVS Caremark Corp. Store Ahead Of Earns
RetailCVS Opens First Pharmacies Within Target Stores
By Phil WahbaFebruary 3, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthTop-Selling Prescription Drugs Have Seen Huge Price Hikes
By Claire GrodenFebruary 2, 2016
Symbolic - biotechnology - genetic engineering
TechGuess What This Early Skype Investor Is Betting on Now
By ReutersFebruary 2, 2016
Key Speakers At The Stanford Institute For Economic Policy Research Forum
LeadershipGilead CEO John Martin Is Stepping Down After 20 Years
By Jen WiecznerJanuary 29, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceBiotech Stocks Crashed and Nobody Knows Why
By Jen WiecznerJanuary 28, 2016
Key Speakers At The 2015 Dell World Conference
FeaturesNew Barbie and Microsoft Earnings—5 Things to Know Today
By Tom Huddleston Jr. and Geoffrey SmithJanuary 28, 2016
Obama Speaks Before Leaving COP21
LeadershipYou’ll Never Guess Who’s Blocking Obama’s FDA Nominee
By Ben GeierJanuary 26, 2016
Johnson & Johnson Products Ahead Of Earnings
HealthDrug Sales Are Driving Johnson & Johnson’s Growth
By Laura LorenzettiJanuary 26, 2016
The Food and Drug Administration
HealthThis Cough Syrup Was Recalled Because It Contains Morphine
By Chris MatthewsJanuary 22, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthMartin Shkreli Is Headed For a Major Showdown With Congress
By ReutersJanuary 22, 2016
BRITAIN-PHARMACEUTICAL-GSK
FinanceFive Charged in U.S. With Stealing Secrets From GlaxoSmithKline
By ReutersJanuary 21, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
HealthValeant Vows to Make Its Drugs ‘Affordable’
By Laura LorenzettiJanuary 13, 2016
Biosimilars Are Coming After Big Pharma’s Bottom Line
HealthBiosimilars Are Coming After Big Pharma’s Bottom Line
By Laura LorenzettiJanuary 12, 2016
1...
  • 81
  • 82
  • 83
  • 84
  • 85
...100
Most Popular
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Investing
Mark Cuban admits he made a mistake letting go of the Mavericks: 'I don't regret selling. I regret who I sold to'placeholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.